3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is growing attracting clinical focus due to sparse information suggesting distinct pharmacological characteristics. Current studies indicate that https://www.pinterest.com/pin/1140888518124046392/